Hypertension and arterial stiffness are major cardiovascular risk factors, and CIT, a NO precursor, has been investigated as a nutritional strategy to lower blood pressure
A series of studies have demonstrated that excessive consumption of high-sugar foods disrupts the body's normal glucose metabolism, leading to metabolic diseases such as diabetes, hypertension, and obesity (108110)
34,35 Subsequently, GLP-1 undergoes enzymatic degradation facilitated by dipeptidyl peptidase IV (DPP-4), leading to the loss of its biological efficacy
Clinical indications and comorbidities play a primary role in medication selection
Patients with type 2 diabetes require careful planning to maintain glycaemic control if GLP-1 therapy is adjusted, with typical perioperative glucose targets of 6-10 mmol/L
Participants in this experiment complained of headache, fatigue, insomnia, intestinal disturbances, and numbness and tingling of their hands and feet (31)